These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

483 related articles for article (PubMed ID: 12960476)

  • 1. Infectious complications in SLE after immunosuppressive therapies.
    Kang I; Park SH
    Curr Opin Rheumatol; 2003 Sep; 15(5):528-34. PubMed ID: 12960476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corticosteroid dose and the risk of opportunistic infection in a national systemic lupus erythematosus cohort.
    Yang SC; Lai YY; Huang MC; Tsai CS; Wang JL
    Lupus; 2018 Oct; 27(11):1819-1827. PubMed ID: 30103646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunosuppressive medication use and risk of herpes zoster (HZ) in patients with systemic lupus erythematosus (SLE): A nationwide case-control study.
    Hu SC; Yen FL; Wang TN; Lin YC; Lin CL; Chen GS
    J Am Acad Dermatol; 2016 Jul; 75(1):49-58. PubMed ID: 26946984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mannose-binding lectin and susceptibility to infection in Chinese patients with systemic lupus erythematosus.
    Mok MY; Ip WK; Lau CS; Lo Y; Wong WH; Lau YL
    J Rheumatol; 2007 Jun; 34(6):1270-6. PubMed ID: 17552055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic lupus erythematosus and risk of infection.
    Barber MRW; Clarke AE
    Expert Rev Clin Immunol; 2020 May; 16(5):527-538. PubMed ID: 32478627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for herpes zoster infection among Filipinos with systemic lupus erythematosus.
    Zamora LD; Collante MTM; Navarra SV
    Int J Rheum Dis; 2020 Feb; 23(2):197-202. PubMed ID: 31692250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for serious infection during treatment with cyclophosphamide and high-dose corticosteroids for systemic lupus erythematosus.
    Pryor BD; Bologna SG; Kahl LE
    Arthritis Rheum; 1996 Sep; 39(9):1475-82. PubMed ID: 8814058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence, risk factors, and outcome of Herpes zoster in systemic lupus erythematosus.
    Borba EF; Ribeiro AC; Martin P; Costa LP; Guedes LK; Bonfá E
    J Clin Rheumatol; 2010 Apr; 16(3):119-22. PubMed ID: 20216330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of immunosuppressive therapies on survival of systemic lupus erythematosus: a propensity score analysis of a longitudinal cohort.
    Mok CC; Tse SM; Chan KL; Ho LY
    Lupus; 2018 Apr; 27(5):722-727. PubMed ID: 29087260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infection risk in systemic lupus erythematosus patients: susceptibility factors and preventive strategies.
    Danza A; Ruiz-Irastorza G
    Lupus; 2013 Oct; 22(12):1286-94. PubMed ID: 24098001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphopenia as risk factor for development of severe infections in patients with systemic lupus erythematosus: a case-control study.
    Merayo-Chalico J; Gómez-Martín D; Piñeirúa-Menéndez A; Santana-De Anda K; Alcocer-Varela J
    QJM; 2013 May; 106(5):451-7. PubMed ID: 23458779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infection in systemic lupus erythematosus.
    Janwityanuchit S; Totemchokchyakarn K; Krachangwongchai K; Vatanasuk M
    J Med Assoc Thai; 1993 Oct; 76(10):542-8. PubMed ID: 7964223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors and prognostic influence of infection in a single cohort of 87 adults with systemic lupus erythematosus.
    Noël V; Lortholary O; Casassus P; Cohen P; Généreau T; André MH; Mouthon L; Guillevin L
    Ann Rheum Dis; 2001 Dec; 60(12):1141-4. PubMed ID: 11709457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of systemic lupus erythematosus: myths, certainties and doubts].
    Ruiz-Irastorza G; Danza A; Khamashta M
    Med Clin (Barc); 2013 Dec; 141(12):533-42. PubMed ID: 23622892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphopaenia, anti-Ro/anti-RNP autoantibodies, renal involvement and cyclophosphamide use correlate with increased risk of herpes zoster in patients with systemic lupus erythematosus.
    Hu SC; Lin CL; Lu YW; Chen GS; Yu HS; Wu CS; Lan CC
    Acta Derm Venereol; 2013 May; 93(3):314-8. PubMed ID: 22983107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of herpes zoster infection with clinical characteristics and MBL2 gene polymorphisms in Chinese children with systemic lupus erythematosus.
    Wu SA; Yeh KW; Yao TC; Huang JL
    Pediatr Infect Dis J; 2011 Aug; 30(8):656-60. PubMed ID: 21343839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opportunistic infections mimicking gastrointestinal vasculitis in systemic lupus erythematosus.
    Diep JT; Kerr LD; Sarebahi S; Tismenetsky M
    J Clin Rheumatol; 2007 Aug; 13(4):213-6. PubMed ID: 17762457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infections in Systemic Lupus Erythematosus.
    Rajadhyaksha AG; Jobanputra K
    J Assoc Physicians India; 2020 May; 68(5):18-21. PubMed ID: 32610860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on cyclophosphamide for systemic lupus erythematosus.
    Ortmann RA; Klippel JH
    Rheum Dis Clin North Am; 2000 May; 26(2):363-75, vii. PubMed ID: 10768217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Invasive fungal infections in Argentine patients with systemic lupus erythematosus.
    Vinicki JP; Catalan Pellet S; Pappalardo C; Cruzat VC; Spinetto MA; Dubinsky D; Tiraboschi IN; Laborde HA; Nasswetter G
    Lupus; 2013 Aug; 22(9):892-8. PubMed ID: 23861029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.